-
1
-
-
77953012692
-
Manifestations and treatment of acute graft-versus-host disease
-
Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds., 4th ed., Oxford, UK: Wiley-Blackwell
-
Cutler C, Antin JH. Manifestations and treatment of acute graft-versus-host disease. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' hematopoietic cell transplantation. 4th ed. Oxford, UK: Wiley-Blackwell, 2009:1287-303.
-
(2009)
Thomas' hematopoietic cell transplantation
, pp. 1287-1303
-
-
Cutler, C.1
Antin, J.H.2
-
2
-
-
84890663488
-
Chronic graft-versus-host disease: clinical manifestations and therapy
-
Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds., 4th ed., Oxford, UK: Wiley-Blackwell
-
Pavletic SZ, Vogelsang GB. Chronic graft-versus-host disease: clinical manifestations and therapy. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' hematopoietic cell transplantation. 4th ed. Oxford, UK: Wiley-Blackwell, 2009:1304-24.
-
(2009)
Thomas' hematopoietic cell transplantation
, pp. 1304-1324
-
-
Pavletic, S.Z.1
Vogelsang, G.B.2
-
3
-
-
0018973048
-
Chronic graftversus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients
-
Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graftversus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
-
(1980)
Am J Med
, vol.69
, pp. 204-217
-
-
Shulman, H.M.1
Sullivan, K.M.2
Weiden, P.L.3
-
4
-
-
28744444180
-
National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group Report
-
Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 2005;11:945-56.
-
(2005)
Biol Blood Marrow Transplant
, vol.11
, pp. 945-956
-
-
Filipovich, A.H.1
Weisdorf, D.2
Pavletic, S.3
-
5
-
-
29844442863
-
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology Working Group Report
-
Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006;12:31-47.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 31-47
-
-
Shulman, H.M.1
Kleiner, D.2
Lee, S.J.3
-
6
-
-
31344452995
-
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report
-
Schultz KR, Miklos DB, Fowler D, et al. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biol Blood Marrow Transplant 2006;12: 126-37.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 126-137
-
-
Schultz, K.R.1
Miklos, D.B.2
Fowler, D.3
-
7
-
-
33244456998
-
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group Report
-
Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group Report. Biol Blood Marrow Transplant 2006; 12:252-66.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 252-266
-
-
Pavletic, S.Z.1
Martin, P.2
Lee, S.J.3
-
8
-
-
33644905065
-
Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report
-
Couriel D, Carpenter PA, Cutler C, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006;12:375-96.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 375-396
-
-
Couriel, D.1
Carpenter, P.A.2
Cutler, C.3
-
9
-
-
33745447476
-
National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group Report
-
Martin PJ, Weisdorf D, Przepiorka D, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group Report. Biol Blood Marrow Transplant 2006;12:491-505.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 491-505
-
-
Martin, P.J.1
Weisdorf, D.2
Przepiorka, D.3
-
10
-
-
9444243839
-
Duration of immunosuppressive treatment for chronic graft-versus-host disease
-
Stewart BL, Storer B, Storek J, et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 2004;104:3501-6.
-
(2004)
Blood
, vol.104
, pp. 3501-3506
-
-
Stewart, B.L.1
Storer, B.2
Storek, J.3
-
11
-
-
70149119758
-
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD
-
Vigorito AC, Campregher PV, Storer BE, et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009;114:702-8.
-
(2009)
Blood
, vol.114
, pp. 702-708
-
-
Vigorito, A.C.1
Campregher, P.V.2
Storer, B.E.3
-
12
-
-
79953109315
-
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
-
Flowers ME, Inamoto Y, Carpenter PA, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011;117:3214-9.
-
(2011)
Blood
, vol.117
, pp. 3214-3219
-
-
Flowers, M.E.1
Inamoto, Y.2
Carpenter, P.A.3
-
13
-
-
79959193801
-
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research Analysis
-
Arora M, Klein JP, Weisdorf DJ, et al. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research Analysis. Blood 2011;117:6714-20.
-
(2011)
Blood
, vol.117
, pp. 6714-6720
-
-
Arora, M.1
Klein, J.P.2
Weisdorf, D.J.3
-
14
-
-
69249193742
-
Standard graft-versushost disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
-
Finke J, Bethge WA, Schmoor C, et al. Standard graft-versushost disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009;10:855-64.
-
(2009)
Lancet Oncol
, vol.10
, pp. 855-864
-
-
Finke, J.1
Bethge, W.A.2
Schmoor, C.3
-
15
-
-
78149464225
-
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire
-
Mohty M, Labopin M, Balère ML, et al. Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire. Leukemia 2010;24:1867-74.
-
(2010)
Leukemia
, vol.24
, pp. 1867-1874
-
-
Mohty, M.1
Labopin, M.2
Balère, M.L.3
-
17
-
-
0019861205
-
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation
-
Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981;304:1529-33.
-
(1981)
N Engl J Med
, vol.304
, pp. 1529-1533
-
-
Weiden, P.L.1
Sullivan, K.M.2
Flournoy, N.3
Storb, R.4
Thomas, E.D.5
-
18
-
-
0024566585
-
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia
-
Sullivan KM, Weiden PL, Storb R, et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989;73: 1720-8.
-
(1989)
Blood
, vol.73
, pp. 1720-1728
-
-
Sullivan, K.M.1
Weiden, P.L.2
Storb, R.3
-
19
-
-
0025100777
-
Graft-versus-leukemia reactions after bone marrow transplantation
-
Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75: 555-62.
-
(1990)
Blood
, vol.75
, pp. 555-562
-
-
Horowitz, M.M.1
Gale, R.P.2
Sondel, P.M.3
-
20
-
-
20144362213
-
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning
-
Baron F, Maris MB, Sandmaier BM, et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Clin Oncol 2005;23:1993-2003.
-
(2005)
Clin Oncol
, vol.23
, pp. 1993-2003
-
-
Baron, F.1
Maris, M.B.2
Sandmaier, B.M.3
-
21
-
-
78149470443
-
The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versushost disease after reduced intensity conditioning before allogeneic stem cell transplantation
-
Thepot S, Zhou J, Perrot A, et al. The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versushost disease after reduced intensity conditioning before allogeneic stem cell transplantation. Leukemia 2010;24:1852-8.
-
(2010)
Leukemia
, vol.24
, pp. 1852-1858
-
-
Thepot, S.1
Zhou, J.2
Perrot, A.3
-
22
-
-
79960451644
-
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation
-
Inamoto Y, Flowers ME, Lee SJ, et al. Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation. Blood 2011;118: 456-63.
-
(2011)
Blood
, vol.118
, pp. 456-463
-
-
Inamoto, Y.1
Flowers, M.E.2
Lee, S.J.3
-
23
-
-
0023713375
-
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation
-
Sullivan KM, Witherspoon RP, Storb R, et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988;72:546-54.
-
(1988)
Blood
, vol.72
, pp. 546-554
-
-
Sullivan, K.M.1
Witherspoon, R.P.2
Storb, R.3
-
24
-
-
0034554783
-
Thalidomide for treatment of patients with chronic graft-versus-host disease
-
Koc S, Leisenring W, Flowers ME, et al. Thalidomide for treatment of patients with chronic graft-versus-host disease. Blood 2000;96:3995-6.
-
(2000)
Blood
, vol.96
, pp. 3995-3996
-
-
Koc, S.1
Leisenring, W.2
Flowers, M.E.3
-
25
-
-
0034962328
-
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
-
Arora M, Wagner JE, Davies SM, et al. Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease. Biol Blood Marrow Transplant 2001; 7:265-73.
-
(2001)
Biol Blood Marrow Transplant
, vol.7
, pp. 265-273
-
-
Arora, M.1
Wagner, J.E.2
Davies, S.M.3
-
26
-
-
0036660429
-
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone
-
Koc S, Leisenring W, Flowers ME, et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 2002; 100:48-51.
-
(2002)
Blood
, vol.100
, pp. 48-51
-
-
Koc, S.1
Leisenring, W.2
Flowers, M.E.3
-
27
-
-
67149108714
-
Evaluation of mycophenolate mofetil for initial treatment of chronic graftversus-host disease
-
Martin PJ, Storer BE, Rowley SD, et al. Evaluation of mycophenolate mofetil for initial treatment of chronic graftversus-host disease. Blood 2009;113:5074-82.
-
(2009)
Blood
, vol.113
, pp. 5074-5082
-
-
Martin, P.J.1
Storer, B.E.2
Rowley, S.D.3
-
28
-
-
84855421339
-
Randomized trial of hydroxychloroquine for newly diagnosed chronic graftversus-host disease in children: a children's oncology group study
-
[Epub ahead of print]
-
Gilman AL, Schultz KR, Goldman FD, et al. Randomized trial of hydroxychloroquine for newly diagnosed chronic graftversus-host disease in children: a children's oncology group study. Biol Blood Marrow Transplant 2011 [Epub ahead of print].
-
(2011)
Biol Blood Marrow Transplant
-
-
Gilman, A.L.1
Schultz, K.R.2
Goldman, F.D.3
-
30
-
-
80054743948
-
Front line treatment of chronic GVHD
-
Vogelsang GB, Pavletic SZ, eds. New York, NY: Cambridge University Press
-
Martin P, Gilman AL. Front line treatment of chronic GVHD. In: Vogelsang GB, Pavletic SZ, eds. Chronic graft versus host disease: interdisciplinary management. New York, NY: Cambridge University Press, 2009:124-33.
-
(2009)
Chronic graft versus host disease: interdisciplinary management
, pp. 124-133
-
-
Martin, P.1
Gilman, A.L.2
-
31
-
-
0037100280
-
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial
-
Flowers ME, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002;100:415-9.
-
(2002)
Blood
, vol.100
, pp. 415-419
-
-
Flowers, M.E.1
Parker, P.M.2
Johnston, L.J.3
-
32
-
-
69849102119
-
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective
-
Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009;15:1143-238.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, pp. 1143-1238
-
-
Tomblyn, M.1
Chiller, T.2
Einsele, H.3
-
33
-
-
0037438514
-
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity
-
Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003;101:407-14.
-
(2003)
Blood
, vol.101
, pp. 407-414
-
-
Boeckh, M.1
Leisenring, W.2
Riddell, S.R.3
-
34
-
-
0000892990
-
Studies on an intermittent corticosteroid dosage regimen
-
Harter JG, Reddy WJ, Thorn GW. Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 1963;269:591-6.
-
(1963)
N Engl J Med
, vol.269
, pp. 591-596
-
-
Harter, J.G.1
Reddy, W.J.2
Thorn, G.W.3
-
35
-
-
77957676790
-
Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD
-
Wolff D, Gerbitz A, Ayuk F, et al. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 2010;16:1611-28.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 1611-1628
-
-
Wolff, D.1
Gerbitz, A.2
Ayuk, F.3
-
36
-
-
79955632748
-
Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease
-
Wolff D, Schleuning M, von Harsdorf S, et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011;17:1-17.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, pp. 1-17
-
-
Wolff, D.1
Schleuning, M.2
von Harsdorf, S.3
-
37
-
-
0036169694
-
A survey of diagnosis, management, and grading of chronic GVHD
-
Lee SJ, Vogelsang G, Gilman A, et al. A survey of diagnosis, management, and grading of chronic GVHD. Biol Blood Marrow Transplant 2002;8:32-9.
-
(2002)
Biol Blood Marrow Transplant
, vol.8
, pp. 32-39
-
-
Lee, S.J.1
Vogelsang, G.2
Gilman, A.3
-
38
-
-
84859819233
-
-
ASBMT eNEWS Survey. Arlington Heights, IL: American Society for Blood and Marrow Transplantation, (Accessed June 15, 2011, at)
-
ASBMT eNEWS Survey. Arlington Heights, IL: American Society for Blood and Marrow Transplantation, 2008. (Accessed June 15, 2011, at http://www.news-source.org/ASBMT/Archive/2008/asbmtonline04-01-08.htm.)
-
(2008)
-
-
-
39
-
-
0032832979
-
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
-
Mookerjee B, Altomonte V, Vogelsang G. Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transplant 1999;24: 517-20.
-
(1999)
Bone Marrow Transplant
, vol.24
, pp. 517-520
-
-
Mookerjee, B.1
Altomonte, V.2
Vogelsang, G.3
-
40
-
-
0034102824
-
Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation
-
Busca A, Saroglia EM, Lanino E, et al. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation. Bone Marrow Transplant 2000;25:1067-71.
-
(2000)
Bone Marrow Transplant
, vol.25
, pp. 1067-1071
-
-
Busca, A.1
Saroglia, E.M.2
Lanino, E.3
-
41
-
-
0036740742
-
Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients
-
Baudard M, Vincent A, Moreau P, Kergueris MF, Harousseau JL, Milpied N. Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients. Marrow Transplant 2002;30: 287-95.
-
(2002)
Marrow Transplant
, vol.30
, pp. 287-295
-
-
Baudard, M.1
Vincent, A.2
Moreau, P.3
Kergueris, M.F.4
Harousseau, J.L.5
Milpied, N.6
-
42
-
-
0038376700
-
Response to mycophenolate mofetil therapy in refractory chronic graftversus-host disease
-
Busca A, Locatelli F, Marmont F, Audisio E, Falda M. Response to mycophenolate mofetil therapy in refractory chronic graftversus-host disease. Haematologica 2003;88:837-9.
-
(2003)
Haematologica
, vol.88
, pp. 837-839
-
-
Busca, A.1
Locatelli, F.2
Marmont, F.3
Audisio, E.4
Falda, M.5
-
43
-
-
3042612312
-
Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant
-
Kim JG, Sohn SK, Kim DH, et al. Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant. Eur J Haematol 2004;73:56-61.
-
(2004)
Eur J Haematol
, vol.73
, pp. 56-61
-
-
Kim, J.G.1
Sohn, S.K.2
Kim, D.H.3
-
44
-
-
27644507409
-
Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
-
Krejci M, Doubek M, Buchler T, Brychtova Y, Vorlicek J, Mayer J. Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease. Ann Hematol 2005; 84:681-5.
-
(2005)
Ann Hematol
, vol.84
, pp. 681-685
-
-
Krejci, M.1
Doubek, M.2
Buchler, T.3
Brychtova, Y.4
Vorlicek, J.5
Mayer, J.6
-
45
-
-
20144388150
-
Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease
-
Lopez F, Parker P, Nademanee A, et al. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2005;11:307-13.
-
(2005)
Biol Blood Marrow Transplant
, vol.11
, pp. 307-313
-
-
Lopez, F.1
Parker, P.2
Nademanee, A.3
-
46
-
-
31644451399
-
Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease
-
Takami A, Mochizuki K, Okumura H, et al. Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease. Int J Hematol 2006;83:80-5.
-
(2006)
Int J Hematol
, vol.83
, pp. 80-85
-
-
Takami, A.1
Mochizuki, K.2
Okumura, H.3
-
47
-
-
77950917873
-
A high risk of lifethreatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
-
Onishi C, Ohashi K, Sawada T, et al. A high risk of lifethreatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease. Int J Hematol 2010;91:464-70.
-
(2010)
Int J Hematol
, vol.91
, pp. 464-470
-
-
Onishi, C.1
Ohashi, K.2
Sawada, T.3
-
48
-
-
75049084631
-
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD
-
Furlong T, Martin P, Flowers ME, et al. Therapy with mycophenolate mofetil for refractory acute and chronic GVHD. Bone Marrow Transplant 2009;44:739-48.
-
(2009)
Bone Marrow Transplant
, vol.44
, pp. 739-748
-
-
Furlong, T.1
Martin, P.2
Flowers, M.E.3
-
49
-
-
0026514939
-
Thalidomide for the treatment of chronic graft-versus-host disease
-
Vogelsang GB, Farmer ER, Hess AD, et al. Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med 1992;326:1055-8.
-
(1992)
N Engl J Med
, vol.326
, pp. 1055-1058
-
-
Vogelsang, G.B.1
Farmer, E.R.2
Hess, A.D.3
-
50
-
-
0028840974
-
Thalidomide as salvage therapy for chronic graft-versus-host disease
-
Parker PM, Chao N, Nademanee A, et al. Thalidomide as salvage therapy for chronic graft-versus-host disease. Blood 1995;86: 3604-9.
-
(1995)
Blood
, vol.86
, pp. 3604-3609
-
-
Parker, P.M.1
Chao, N.2
Nademanee, A.3
-
51
-
-
0031884832
-
The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
-
Rovelli A, Arrigo C, Nesi F, et al. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Bone Marrow Transplant 1998;21:577-81.
-
(1998)
Bone Marrow Transplant
, vol.21
, pp. 577-581
-
-
Rovelli, A.1
Arrigo, C.2
Nesi, F.3
-
52
-
-
0033754011
-
Response to thalidomide therapy in refractory chronic graft-versus-host disease
-
Browne PV, Weisdorf DJ, DeFor T, et al. Response to thalidomide therapy in refractory chronic graft-versus-host disease. Bone Marrow Transplant 2000;26:865-9.
-
(2000)
Bone Marrow Transplant
, vol.26
, pp. 865-869
-
-
Browne, P.V.1
Weisdorf, D.J.2
DeFor, T.3
-
53
-
-
0034907091
-
The use of thalidomide in chronic refractory graft versus host disease
-
van de Poel MH, Pasman PC, Schouten HC. The use of thalidomide in chronic refractory graft versus host disease. Neth J Med 2001;59:45-9.
-
(2001)
Neth J Med
, vol.59
, pp. 45-49
-
-
van de Poel, M.H.1
Pasman, P.C.2
Schouten, H.C.3
-
54
-
-
10744230404
-
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease
-
Kulkarni S, Powles R, Sirohi B, et al. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease. Bone Marrow Transplant 2003;32:165-70.
-
(2003)
Bone Marrow Transplant
, vol.32
, pp. 165-170
-
-
Kulkarni, S.1
Powles, R.2
Sirohi, B.3
-
55
-
-
56549114909
-
Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease
-
Flowers ME, Storer B, Carpenter P, et al. Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease. Biol Blood Marrow Transplant 2008; 14:1380-4.
-
(2008)
Biol Blood Marrow Transplant
, vol.14
, pp. 1380-1384
-
-
Flowers, M.E.1
Storer, B.2
Carpenter, P.3
-
56
-
-
3042651139
-
Grading quality of evidence and strength of recommendations
-
Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
-
(2004)
BMJ
, vol.328
, pp. 1490
-
-
Atkins, D.1
Best, D.2
Briss, P.A.3
-
57
-
-
79955984501
-
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
-
Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117:4190-207.
-
(2011)
Blood
, vol.117
, pp. 4190-4207
-
-
Neunert, C.1
Lim, W.2
Crowther, M.3
Cohen, A.4
Solberg Jr., L.5
Crowther, M.A.6
-
58
-
-
33745964855
-
Rituximab for steroidrefractory chronic graft-versus-host disease
-
Cutler C, Miklos D, Kim HT, et al. Rituximab for steroidrefractory chronic graft-versus-host disease. Blood 2006;108: 756-62.
-
(2006)
Blood
, vol.108
, pp. 756-762
-
-
Cutler, C.1
Miklos, D.2
Kim, H.T.3
-
60
-
-
56049118902
-
Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab
-
von Bonin M, Oelschlägel U, Radke J, et al. Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab. Transplantation 2008;86:875-9.
-
(2008)
Transplantation
, vol.86
, pp. 875-879
-
-
von Bonin, M.1
Oelschlägel, U.2
Radke, J.3
-
61
-
-
78149243861
-
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study
-
Kim SJ, Lee JW, Jung CW, et al. Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study. Haematologica 2010;95:1935-42.
-
(2010)
Haematologica
, vol.95
, pp. 1935-1942
-
-
Kim, S.J.1
Lee, J.W.2
Jung, C.W.3
-
62
-
-
70149123508
-
Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease
-
Magro L, Mohty M, Catteau B, et al. Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease. Blood 2009;114:719-22.
-
(2009)
Blood
, vol.114
, pp. 719-722
-
-
Magro, L.1
Mohty, M.2
Catteau, B.3
-
63
-
-
70149102515
-
Imatinib for refractory chronic graft-versus-host disease with fibrotic features
-
Olivieri A, Locatelli F, Zecca M, et al. Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood 2009;114:709-18.
-
(2009)
Blood
, vol.114
, pp. 709-718
-
-
Olivieri, A.1
Locatelli, F.2
Zecca, M.3
-
64
-
-
34948840917
-
Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease
-
Jacobsohn DA, Chen AR, Zahurak M, et al. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol 2007;25:4255-61.
-
(2007)
J Clin Oncol
, vol.25
, pp. 4255-4261
-
-
Jacobsohn, D.A.1
Chen, A.R.2
Zahurak, M.3
-
65
-
-
73349089953
-
Evaluation of pentostatin in corticosteroid-refractory chronic graft-versushost disease in children: a Pediatric Blood and Marrow Transplant Consortium Study
-
Jacobsohn DA, Gilman AL, Rademaker A, et al. Evaluation of pentostatin in corticosteroid-refractory chronic graft-versushost disease in children: a Pediatric Blood and Marrow Transplant Consortium Study. Blood 2009;114:4354-60.
-
(2009)
Blood
, vol.114
, pp. 4354-4360
-
-
Jacobsohn, D.A.1
Gilman, A.L.2
Rademaker, A.3
-
66
-
-
78651251952
-
Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host disease
-
Pidala J, Kim J, Roman-Diaz J, et al. Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host disease. Ann Transplant 2010;15:21-9.
-
(2010)
Ann Transplant
, vol.15
, pp. 21-29
-
-
Pidala, J.1
Kim, J.2
Roman-Diaz, J.3
-
67
-
-
78650208987
-
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
-
Weng JY, Du X, Geng SX, et al. Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant 2010;45:1732-40.
-
(2010)
Bone Marrow Transplant
, vol.45
, pp. 1732-1740
-
-
Weng, J.Y.1
Du, X.2
Geng, S.X.3
-
68
-
-
0032212219
-
Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease
-
Greinix HT, Volc-Platzer B, Rabitsch W, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998;92: 3098-104.
-
(1998)
Blood
, vol.92
, pp. 3098-3104
-
-
Greinix, H.T.1
Volc-Platzer, B.2
Rabitsch, W.3
-
69
-
-
0031615427
-
Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs-host disease
-
Smith EP, Sniecinski I, Dagis AC, et al. Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease. Biol Blood Marrow Transplant 1998;4:27-37.
-
(1998)
Biol Blood Marrow Transplant
, vol.4
, pp. 27-37
-
-
Smith, E.P.1
Sniecinski, I.2
Dagis, A.C.3
-
70
-
-
0032957559
-
Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)
-
Child FJ, Ratnavel R, Watkins P, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1999;23:881-7.
-
(1999)
Bone Marrow Transplant
, vol.23
, pp. 881-887
-
-
Child, F.J.1
Ratnavel, R.2
Watkins, P.3
-
71
-
-
0035469829
-
Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease
-
Alcindor T, Gorgun G, Miller KB, et al. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood 2001;98:1622-5.
-
(2001)
Blood
, vol.98
, pp. 1622-1625
-
-
Alcindor, T.1
Gorgun, G.2
Miller, K.B.3
-
72
-
-
0034782157
-
Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood
-
Salvaneschi L, Perotti C, Zecca M, et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001;41:1299-305.
-
(2001)
Transfusion
, vol.41
, pp. 1299-1305
-
-
Salvaneschi, L.1
Perotti, C.2
Zecca, M.3
-
73
-
-
0242417628
-
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results
-
Apisarnthanarax N, Donato M, Körbling M, et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003;31:459-65.
-
(2003)
Bone Marrow Transplant
, vol.31
, pp. 459-465
-
-
Apisarnthanarax, N.1
Donato, M.2
Körbling, M.3
-
74
-
-
0038345300
-
Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation
-
Messina C, Locatelli F, Lanino E, et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003;122:118-27.
-
(2003)
Br J Haematol
, vol.122
, pp. 118-127
-
-
Messina, C.1
Locatelli, F.2
Lanino, E.3
-
75
-
-
0043240283
-
Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response
-
Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003;102:1217-23.
-
(2003)
Blood
, vol.102
, pp. 1217-1223
-
-
Seaton, E.D.1
Szydlo, R.M.2
Kanfer, E.3
Apperley, J.F.4
Russell-Jones, R.5
-
76
-
-
21244484653
-
Prospective study of extracorporeal photopheresis in steroid-refractory or steroidresistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors
-
Foss FM, DiVenuti GM, Chin K, et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroidresistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005;35:1187-93.
-
(2005)
Bone Marrow Transplant
, vol.35
, pp. 1187-1193
-
-
Foss, F.M.1
DiVenuti, G.M.2
Chin, K.3
-
77
-
-
24944534610
-
Role of extracorporeal photochemotherapy in patients with refractory chronic graftversus-host disease
-
Rubegni P, Cuccia A, Sbano P, et al. Role of extracorporeal photochemotherapy in patients with refractory chronic graftversus-host disease. Br J Haematol 2005;130:271-5.
-
(2005)
Br J Haematol
, vol.130
, pp. 271-275
-
-
Rubegni, P.1
Cuccia, A.2
Sbano, P.3
-
78
-
-
33745795381
-
Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy
-
Bisaccia E, Palangio M, Gonzalez J, et al. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy. J Clin Apher 2006;21:181-7.
-
(2006)
J Clin Apher
, vol.21
, pp. 181-187
-
-
Bisaccia, E.1
Palangio, M.2
Gonzalez, J.3
-
79
-
-
33645733724
-
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD
-
Couriel DR, Hosing C, Saliba R, et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006;107:3074-80.
-
(2006)
Blood
, vol.107
, pp. 3074-3080
-
-
Couriel, D.R.1
Hosing, C.2
Saliba, R.3
-
80
-
-
35148896347
-
Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report
-
Berger M, Pessolano R, Albiani R, et al. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report. J Pediatr Hematol Oncol 2007;29:678-87.
-
(2007)
J Pediatr Hematol Oncol
, vol.29
, pp. 678-687
-
-
Berger, M.1
Pessolano, R.2
Albiani, R.3
-
81
-
-
33947422891
-
Extracorporeal photochemotherapy for the treatment of chronic graft-versushost disease: trend for a possible cell dose-related effect?
-
Perseghin P, Galimberti S, Balduzzi A, et al. Extracorporeal photochemotherapy for the treatment of chronic graft-versushost disease: trend for a possible cell dose-related effect? Ther Apher Dial 2007;11:85-93.
-
(2007)
Ther Apher Dial
, vol.11
, pp. 85-93
-
-
Perseghin, P.1
Galimberti, S.2
Balduzzi, A.3
-
82
-
-
53449088758
-
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
-
Flowers ME, Apperley JF, van Besien K, et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008;112:2667-74.
-
(2008)
Blood
, vol.112
, pp. 2667-2674
-
-
Flowers, M.E.1
Apperley, J.F.2
van Besien, K.3
-
83
-
-
69749096116
-
Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)
-
Jagasia MH, Savani BN, Stricklin G, et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol Blood Marrow Transplant 2009;15:1288-95.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, pp. 1288-1295
-
-
Jagasia, M.H.1
Savani, B.N.2
Stricklin, G.3
-
84
-
-
77953106593
-
Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients
-
Perotti C, Del Fante C, Tinelli C, et al. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Transfusion 2010;50:1359-69.
-
(2010)
Transfusion
, vol.50
, pp. 1359-1369
-
-
Perotti, C.1
Del Fante, C.2
Tinelli, C.3
-
85
-
-
0026349522
-
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation
-
Tzakis AG, Abu-Elmagd K, Fung JJ, et al. FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. Transplant Proc 1991;23:3225-7.
-
(1991)
Transplant Proc
, vol.23
, pp. 3225-3227
-
-
Tzakis, A.G.1
Abu-Elmagd, K.2
Fung, J.J.3
-
86
-
-
0029062592
-
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants
-
Kanamaru A, Takemoto Y, Kakishita E, et al. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. Bone Marrow Transplant 1995;15:885-9.
-
(1995)
Japanese FK506 BMT Study Group. Bone Marrow Transplant
, vol.15
, pp. 885-889
-
-
Kanamaru, A.1
Takemoto, Y.2
Kakishita, E.3
-
87
-
-
0033657112
-
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease
-
Carnevale-Schianca F, Martin P, Sullivan K, et al. Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease. Biol Blood Marrow Transplant 2000; 6:613-20.
-
(2000)
Biol Blood Marrow Transplant
, vol.6
, pp. 613-620
-
-
Carnevale-Schianca, F.1
Martin, P.2
Sullivan, K.3
-
88
-
-
0030945010
-
Treatment of chronic graft-versus-host disease with clofazimine
-
Lee SJ, Wegner SA, McGarigle CJ, Bierer BE, Antin JH. Treatment of chronic graft-versus-host disease with clofazimine. Blood 1997;89:2298-302.
-
(1997)
Blood
, vol.89
, pp. 2298-2302
-
-
Lee, S.J.1
Wegner, S.A.2
McGarigle, C.J.3
Bierer, B.E.4
Antin, J.H.5
-
89
-
-
24944570255
-
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease
-
Couriel DR, Saliba R, Escalón MP, et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol 2005;130:409-17.
-
(2005)
Br J Haematol
, vol.130
, pp. 409-417
-
-
Couriel, D.R.1
Saliba, R.2
Escalón, M.P.3
-
90
-
-
11244289077
-
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease
-
Johnston LJ, Brown J, Shizuru JA, et al. Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2005;11:47-55.
-
(2005)
Biol Blood Marrow Transplant
, vol.11
, pp. 47-55
-
-
Johnston, L.J.1
Brown, J.2
Shizuru, J.A.3
-
91
-
-
34248652434
-
Sirolimus as part of immunosuppressive therapy for refractory chronic graftversus-host disease
-
Jurado M, Vallejo C, Pérez-Simón JA, et al. Sirolimus as part of immunosuppressive therapy for refractory chronic graftversus-host disease. Biol Blood Marrow Transplant 2007;13: 701-6.
-
(2007)
Biol Blood Marrow Transplant
, vol.13
, pp. 701-706
-
-
Jurado, M.1
Vallejo, C.2
Pérez-Simón, J.A.3
-
92
-
-
79954602530
-
Therapy of sclerodermatous chronic graftversus-host disease with mammalian target of rapamycin inhibitors
-
Jedlickova Z, Burlakova I, Bug G, Baurmann H, Schwerdtfeger R, Schleuning M. Therapy of sclerodermatous chronic graftversus-host disease with mammalian target of rapamycin inhibitors. Biol Blood Marrow Transplant 2011;17:657-63.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, pp. 657-663
-
-
Jedlickova, Z.1
Burlakova, I.2
Bug, G.3
Baurmann, H.4
Schwerdtfeger, R.5
Schleuning, M.6
-
93
-
-
0037181125
-
Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease
-
Chiang KY, Abhyankar S, Bridges K, Godder K, Henslee-Downey JP. Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease. Transplantation 2002;73:665-7.
-
(2002)
Transplantation
, vol.73
, pp. 665-667
-
-
Chiang, K.Y.1
Abhyankar, S.2
Bridges, K.3
Godder, K.4
Henslee-Downey, J.P.5
-
94
-
-
23944454392
-
Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease
-
Giaccone L, Martin P, Carpenter P, et al. Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease. Bone Marrow Transplant 2005;36: 337-41.
-
(2005)
Bone Marrow Transplant
, vol.36
, pp. 337-341
-
-
Giaccone, L.1
Martin, P.2
Carpenter, P.3
-
95
-
-
23944519423
-
Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
-
Huang XJ, Jiang Q, Chen H, et al. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005;36:343-8.
-
(2005)
Bone Marrow Transplant
, vol.36
, pp. 343-348
-
-
Huang, X.J.1
Jiang, Q.2
Chen, H.3
-
96
-
-
41549166180
-
Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children
-
Inagaki J, Nagatoshi Y, Hatano M, Isomura N, Sakiyama M, Okamura J. Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children. Bone Marrow Transplant 2008;41:571-7.
-
(2008)
Bone Marrow Transplant
, vol.41
, pp. 571-577
-
-
Inagaki, J.1
Nagatoshi, Y.2
Hatano, M.3
Isomura, N.4
Sakiyama, M.5
Okamura, J.6
-
97
-
-
25444491999
-
Low-dose thoracoabdominal irradiation for the treatment of refractory chronic graft-versus-host disease
-
Robin M, Guardiola P, Girinsky T, et al. Low-dose thoracoabdominal irradiation for the treatment of refractory chronic graft-versus-host disease. Transplantation 2005;80:634-42.
-
(2005)
Transplantation
, vol.80
, pp. 634-642
-
-
Robin, M.1
Guardiola, P.2
Girinsky, T.3
-
98
-
-
0034781710
-
A high-dose pulse steroid regimen for controlling active chronic graftversus-host disease
-
Akpek G, Lee SM, Anders V, Vogelsang GB. A high-dose pulse steroid regimen for controlling active chronic graftversus-host disease. Biol Blood Marrow Transplant 2001;7:495-502.
-
(2001)
Biol Blood Marrow Transplant
, vol.7
, pp. 495-502
-
-
Akpek, G.1
Lee, S.M.2
Anders, V.3
Vogelsang, G.B.4
-
99
-
-
0033642532
-
Hydroxychloroquine for the treatment of chronic graft-versus-host disease
-
Gilman AL, Chan KW, Mogul A, et al. Hydroxychloroquine for the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2000;6:327-34.
-
(2000)
Biol Blood Marrow Transplant
, vol.6
, pp. 327-334
-
-
Gilman, A.L.1
Chan, K.W.2
Mogul, A.3
-
101
-
-
0032933608
-
Etretinate therapy for refractory sclerodermatous chronic graft-versushost disease
-
Marcellus DC, Altomonte VL, Farmer ER, et al. Etretinate therapy for refractory sclerodermatous chronic graft-versushost disease. Blood 1999;93:66-70.
-
(1999)
Blood
, vol.93
, pp. 66-70
-
-
Marcellus, D.C.1
Altomonte, V.L.2
Farmer, E.R.3
-
102
-
-
58249097301
-
Feasibility of NIH consensus criteria for chronic graft-versus-host disease
-
Cho BS, Min CK, Eom KS, et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009; 23:78-84.
-
(2009)
Leukemia
, vol.23
, pp. 78-84
-
-
Cho, B.S.1
Min, C.K.2
Eom, K.S.3
-
103
-
-
80054090049
-
Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria
-
[Epub ahead of print]
-
Arai S, Jagasia M, Storer B, et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 2011 [Epub ahead of print].
-
(2011)
Blood
-
-
Arai, S.1
Jagasia, M.2
Storer, B.3
-
104
-
-
79956201323
-
Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease
-
Martin PJ, Storer BE, Carpenter PA, et al. Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011;17:124-32.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, pp. 124-132
-
-
Martin, P.J.1
Storer, B.E.2
Carpenter, P.A.3
-
105
-
-
67650302854
-
Phase II trials in journal of clinical oncology
-
Cannistra SA. Phase II trials in journal of clinical oncology. J Clin Oncol 2009;27:3073-6.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3073-3076
-
-
Cannistra, S.A.1
-
106
-
-
84859840895
-
-
Alexandria, VA: The American Society of Clinical Oncology (Accessed July 20, at)
-
Journal of Clinical Oncology Information for Contributors. Alexandria, VA: The American Society of Clinical Oncology (Accessed July 20, 2011, at http://jco.ascopubs.org/site/ifc/ categories.xhtml.)
-
(2011)
Journal of Clinical Oncology Information for Contributors
-
-
|